European Society of Organ Transplantation Consensus Statement on Testing for Non-Invasive Diagnosis of Kidney Allograft Rejection

Transpl Int. 2024 Jan 4:36:12115. doi: 10.3389/ti.2023.12115. eCollection 2023.

Abstract

To address the need for improved biomarkers for kidney transplant rejection, European Society of Organ Transplantation (ESOT) convened a dedicated working group comprised of experts in kidney transplant biomarkers to review literature pertaining to clinical and subclinical acute rejection to develop guidelines in the screening and diagnosis of acute rejection that were subsequently discussed and voted on during the Consensus Conference that took place in person in Prague. The findings and recommendations of the Working Group on Molecular Biomarkers of Kidney Transplant Rejection are presented in this article.

Keywords: biomarkers; cell-free DNA; diagnostics; gene expression; kidney transplant; non-invasive; rejection; urine chemokines.

MeSH terms

  • Allografts
  • Biomarkers
  • Graft Rejection* / diagnosis
  • Graft Rejection* / prevention & control
  • Humans
  • Kidney
  • Organ Transplantation*

Substances

  • Biomarkers

Grants and funding

All costs related to taskforce and workgroup meetings were covered by ESOT, without external funding.